Monarch Medical Technologies to Convene Industry Leaders in Inpatient Diabetes Management for Second Annual EndoTool User Group Meeting

Healthcare professionals from leading systems gather to share best practices using EndoTool IV and EndoTool SubQ across hospital units and patient populations.

Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced that they will be hosting their annual EndoTool User Group Meeting on October 18th at the Ballantyne Hotel in Charlotte, NC. The event provides an opportunity for users of the EndoTool platform to share best practices, network with peers and discuss strategies to improve glycemic management across the continuum of care.

The agenda includes industry thought leaders across numerous organizations sharing change management strategies, industry trends in glucose management, and clinical results using EndoTool.

Agenda highlights and speakers at the 2018 EndoTool User Group Meeting include:

  • Caroline Isbey, RN, MSN, CDE, Associate Director of Accreditation and Certification at the Joint Commission, providing an overview of their program and steps organizations can take to achieve certification.
  • Sandy Fogel, MD, FACS of Carilion Clinic, an expert of quality improvement, sharing strategies to master change management in the healthcare setting.
  • Cynde Adorno, BSN, RN, CCRN from Grand Strand Medical Center, Lisa Clement-Bryant, MSN, RN, CDE, CPT from CaroMont Health, and RaShaye Freeman, DNP, FNP-BC, CDE, ADM-BC from HCA discussing the pivotal role of nursing leadership in implementing and instilling glycemic management processes and practices during a panel discussion.
  • Maresa Glass, PharmD, BCPS, BCCCP of Tampa General Hospital presenting their experience and results using EndoTool IV within labor and delivery.

“Our EndoTool User Group Meeting provides an open forum for our customers to learn from one another, share their feedback to shape future product development, and collectively discuss how we can advance inpatient diabetes care,” said Linda Beneze, President and CEO of Monarch Medical Technologies. “We look forward to once again bringing together healthcare professionals dedicated to improving the safety, cost, and quality of care through optimized glycemic management.”

The 2018 EndoTool User Group Meeting takes place on October 18th.

About Monarch Medical Technologies

Monarch Medical Technologies is the leading provider of electronic systems for inpatient glycemic management. Monarch’s EndoTool Glucose Management System offers personalized dosing recommendations for intravenous and subcutaneous insulin therapy. As a Class II FDA-cleared, patented software suite, EndoTool has enabled more than 245 hospitals to provide unsurpassed patient-specific glycemic control across a broad population of patients, and ultimately deliver better, safer care. For more information, please visit